ArticleLung India : official organ of Indian Chest Society
Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario.
Sayanta Thakur et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.